DCVC, a venture capital firm, and NVentures, a venture capital arm of NVIDIA, led a $35m round in Relation Therapeutics, a virtual drug discovery specialist, with participation from Magnetic Ventures, Khosla Ventures, Jonathan Milner, ARK Invest and Deerfield Management Company. "This financing is a significant milestone for Relation Therapeutics and underscores the confidence our investors have in our innovative approach to drug discovery and development. Our technology platform, uniquely integrated with deep R&D expertise, places us in an outstanding position to transform drug discovery. This new capital allows us to accelerate our discovery of novel biology, targets and medicines: we are immensely excited about our progress and the impact we can make for patients," David Roblin, Relation Therapeutics CEO.